Beginning 8/24/2021, CCH will resume administration of SAR-CoV-2 monoclonal antibody (SMA) therapy. Referrals may be made by faxing the referral form or be made in PennChart by ordering “CONSULT TO SARS-COV-2 MONOCLONAL ANTIBODY” and selecting CCH as the preferred location.
The service is offered by appointment only Tuesdays and Thursdays only.
The emergency department does not administer the therapy nor does it make priority referrals to the monoclonal therapy service. Referrals are triaged based on patient risk factors.